Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 425-432, 2003; 10.1373/49.3.425
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Øvstebø, R.
Right arrow Articles by Kierulf, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Øvstebø, R.
Right arrow Articles by Kierulf, P.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2003;49:425-432.)
© 2003 American Association for Clinical Chemistry, Inc.

PCR-based Calibration Curves for Studies of Quantitative Gene Expression in Human Monocytes: Development and Evaluation

Reidun Øvstebøa1, Kari Bente Foss Haug1, Knut Lande1 and Peter Kierulf1

1 The Research and Development Group, Department of Clinical Chemistry, Ullevål University Hospital, 0407 Oslo, Norway.

aAuthor for correspondence. Fax 47-22118189; e-mail reidun.ovstebo{at}ioks.uio.no.

Background: Quantitative reverse transcription-PCR (RT-PCR) used to detect small changes in specific mRNA concentrations is often associated with poor reproducibility. Thus, there is a need for stringent quality control in each step of the protocol.

Methods: Real-time PCR-based calibration curves for a target gene, tissue factor (TF), and a reference gene, ß-actin, generated from PCR amplicons were evaluated by running cDNA controls. In addition, the reverse transcription step was evaluated by running mRNA controls. Amplification efficiencies of calibrators and targets were determined. Variances within and between runs were estimated, and power statistics were applied to determine the concentration differences that could reliably be detected.

Results: Within- and between-run variations (CVs) of cDNA controls (TF and ß-actin), extrapolated from reproducible calibration curves (CVs of slopes, 4.3% and 2.7%, respectively) were 4–10% (within) and 15–38% (between) using both daily and "grand mean" calibration curves. CVs for the ß-actin mRNA controls were 12% (within) and 19–28% (between). Estimates of each step’s contribution to the total variation were as follows: CVRT-PCR, 28%; CVPCR, 15%; CVRT, 23% (difference between CVRT-PCR and CVPCR). PCR efficiencies were as follows: ß-actin calibrator/target, 1.96/1.95; TF calibrator/target, 1.95/1.93. Duplicate measurements could detect a twofold concentration difference (power, 0.8).

Conclusions: Daily PCR calibration curves generated from PCR amplicons were reproducible, allowing the use of a grand mean calibration curve. The reverse transcription step contributes the most to the total variation. By determining a system’s total variance, power analysis may be used to disclose differences that can be reliably detected at a specified power.




The following articles in journals at HighWire Press have cited this article:


Home page
J. Gen. Virol.Home page
L. Struijk, E. van der Meijden, S. Kazem, J. ter Schegget, F. R. de Gruijl, R. D. M. Steenbergen, and M. C. W. Feltkamp
Specific betapapillomaviruses associated with squamous cell carcinoma of the skin inhibit UVB-induced apoptosis of primary human keratinocytes
J. Gen. Virol., September 1, 2008; 89(9): 2303 - 2314.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Woelfelschneider, O. Popanda, C. Lilla, J. Linseisen, C. Mayer, O. Celebi, J. Debus, H. Bartsch, J. Chang-Claude, and P. Schmezer
A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients
Carcinogenesis, September 1, 2008; 29(9): 1758 - 1764.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. Ovstebo, O. K. Olstad, B. Brusletto, A. S. Moller, A. Aase, K. B. F. Haug, P. Brandtzaeg, and P. Kierulf
Identification of Genes Particularly Sensitive to Lipopolysaccharide (LPS) in Human Monocytes Induced by Wild-Type versus LPS-Deficient Neisseria meningitidis Strains
Infect. Immun., June 1, 2008; 76(6): 2685 - 2695.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Krop, A. Marz, H. Carlsson, X. Li, N. Bloushtain-Qimron, M. Hu, R. Gelman, M. S. Sabel, S. Schnitt, S. Ramaswamy, et al.
A Putative Role for Psoriasin in Breast Tumor Progression
Cancer Res., December 15, 2005; 65(24): 11326 - 11334.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
E. Zygalaki, A. Stathopoulou, C. Kroupis, L. Kaklamanis, Z. Kyriakides, D. Kremastinos, and E. S. Lianidou
Real-Time Reverse Transcription-PCR Quantification of Vascular Endothelial Growth Factor Splice Variants
Clin. Chem., August 1, 2005; 51(8): 1518 - 1520.
[Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A.-K. Fjeldheim, P. I. Hovring, O.-P. Loseth, P. W. Johansen, J. C Glover, V. Matre, O. K. Olstad, S. Reppe, J. O Gordeladze, S I. Walaas, et al.
Thyrotrophin-releasing hormone receptor 1 and prothyrotrophin-releasing hormone mRNA expression in the central nervous system are regulated by suckling in lactating rats
Eur. J. Endocrinol., May 1, 2005; 152(5): 791 - 803.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
P de Cremoux, I Bieche, C Tran-Perennou, S Vignaud, E Boudou, B Asselain, R Lidereau, H Magdelenat, V Becette, B Sigal-Zafrani, et al.
Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction
Endocr. Relat. Cancer, September 1, 2004; 11(3): 489 - 495.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
R. Ovstebo, P. Brandtzaeg, B. Brusletto, K. B. F. Haug, K. Lande, E. A. Hoiby, and P. Kierulf
Use of Robotized DNA Isolation and Real-Time PCR To Quantify and Identify Close Correlation between Levels of Neisseria meningitidis DNA and Lipopolysaccharides in Plasma and Cerebrospinal Fluid from Patients with Systemic Meningococcal Disease
J. Clin. Microbiol., July 1, 2004; 42(7): 2980 - 2987.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
A.-S. W. Moller, R. Ovstebo, A.-B. Westvik, G. B. Joo, K.-B. F. Haug, and P. Kierulf
Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1{alpha} (MIP-1{alpha}) and the chemokine receptor CCR2 by purified human blood monocytes
Innate Immunity, December 1, 2003; 9(6): 349 - 360.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.